Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T21:54:31.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:28:11.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional studies being included in the database.
    Difference
    0.3%
    Check dated 2024-05-22T20:55:06.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value 01 23 has been updated to 05 20 on the webpage, indicating a recent change in the data related to Medical and healthcare publications and documentation.
    Difference
    0.7%
    Check dated 2024-05-21T14:15:55.000Z thumbnail image
  9. Check
    45 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:21:38.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.